Citi’s 11%+ RoTCE Target Signals Stronger Capital Efficiency
Citigroup Inc.
Articles by Vardah Gill
Lilly’s Foundayo Quickly Gains Ground in the Oral Weight-Loss Market
Eli Lilly and Company (NYSE:LLY) says its newly launched oral obesity drug Foundayo has captured more than 30% of new U.S.
Abbott Faces $384 Million Cost as Infant Formula Legal Risks Persist
Abbott Laboratories (NYSE:ABT) has agreed to pay more than $384 million to resolve U.S.
Bank of America Warns of 10%+ Drop in Q3 Investment Banking Fees
Bank of America Corporation (NYSE:BAC) expects third-quarter investment banking fees to fall by at least 10% year over year, which highlights a broader normalization across capital...
BioNTech’s Lung Cancer Drug Shows Signs of a Major Breakthrough
BioNTech SE (NASDAQ:BNTX) reported that its investigational lung-cancer drug gotistobart produced a clinically meaningful overall-survival benefit in the Phase 3 PRESERVE-003 ...
From Novo Nordisk to ‘Novo’: A Strategic Reset Amid Rising Lilly Pressure
Novo Nordisk A/S (NYSE:NVO)'s decision to rebrand its day-to-day identity as “Novo” and launch a cultural reset is primarily a strategic response to the company’s loss of...
Kimberly-Clark Moves to Clear EU Hurdle with Kenvue Asset Sales
Kimberly-Clark Corporation (NASDAQ:KMB) is preparing asset sales to address EU antitrust concerns surrounding its planned $40 billion acquisition of Kenvue, according to Reuters...
Oracle Adds $700 Million to the Cost of its AI Transformation
Oracle Corporation (NYSE:ORCL) is increasing the expected cost of its fiscal 2026 restructuring plan by about $700 million to roughly $2.8 billion as it simultaneously ramps up...
Nvidia’s Anthropic Investment: Securing AI Demand Amid Rising Competition
On September 13, Reuters reported that Anthropic is in talks to bring NVIDIA Corporation (NASDAQ:NVDA) in as an anchor investor in what could become one of the largest IPOs in...
AstraZeneca’s Oncology Engine Faces a Key Test After Camizestrant Miss
AstraZeneca PLC (NYSE:AZN)'s breast cancer pill Etcamah (camizestrant) failed to meet the primary endpoint in the Phase III SERENA-4 trial, dealing a setback to one of the company...
GSK Cuts 641 Jobs in Vaccine Manufacturing Restructuring
GSK plc (NYSE:GSK) plans to close its vaccine manufacturing facility in Dresden, Germany, by summer 2027, putting 641 jobs at risk.
Colgate-Palmolive Seeks Value Through Portfolio Reshaping
Colgate-Palmolive Company (NYSE:CL) is reportedly exploring the sale of several mass-market personal care brands, including Softsoap, Irish Spring and Speed Stick, in a portfolio...
Dell Seeks $4 Billion as AI Boom Fuels Growth and Debt Management
Dell Technologies Inc. (NYSE:DELL) is looking to raise roughly $4 billion through an investment-grade bond sale, mainly to refinance debt coming due in 2026.
UnitedHealth Partners with TPG to Strengthen Underperforming Florida Clinics
UnitedHealth Group Incorporated (NYSE:UNH) has sold an interest in some of its Optum Health operations in Florida to private-equity firm TPG, specifically involving its WellMed...
Walmart (WMT) Delivery Push Gains Momentum with Papa John’s Partnership
Walmart Inc. (NASDAQ:WMT) is expanding its restaurant-delivery business through a partnership with Papa John’s, allowing customers in select U.S.
Energy Transfer’s Texas Listing Could Boost Visibility, but Risks Remain
Energy Transfer LP (NYSE:ET) is set to move the primary listing of its common and Series I preferred units from the New York Stock Exchange to the Texas Stock Exchange in early...
Novo Nordisk Expands Wegovy’s Reach with China MASH Approval
Novo Nordisk A/S (NYSE:NVO) has received approval in China for Wegovy to treat metabolic dysfunction-associated steatohepatitis (MASH), making it the first GLP-1 receptor agonist...
IBM Takes its AI Strategy Beyond Earth with NASA Lunar Model
International Business Machines Corporation (NYSE:IBM) and NASA have released the NASA-IBM Lunar Foundation Model, an open-source AI model designed to analyze decades of lunar...
The Cooper Companies (COO) Faces Near-Term Pressure from Slowing Contact Lens Demand
The Cooper Companies, Inc.
Enbridge (ENB) Expands its U.S. Oil Footprint with Tallgrass Acquisition
Enbridge Inc. (NYSE:ENB) has agreed to buy Blackstone-owned Tallgrass Energy’s crude oil business for $2.55 billion in cash, expanding its presence in the U.S.
TotalEnergies (TTE) Sees Long-Term Potential in Angola’s Offshore Oil
TotalEnergies SE (NYSE:TTE) plans to invest $10 billion alongside its partners in Angola over the next five years, with the goal of maintaining and potentially increasing its ...
Marriott International (MAR)’s Middle East Headwind Eases, but War Risks Remain
Marriott International, Inc.
HSBC Holdings (HSBC) Reshapes European Operations with German Exit
HSBC Holdings plc (NYSE:HSBC) is winding down its transaction services business in Germany, with more than 300 positions at HSBC Transaction Services GmbH and HSBC Service Company...
Booking Holdings (BKNG)’s Growth Strategy Hits an EU Roadblock
Booking Holdings Inc. (NASDAQ:BKNG) has lost its legal fight against the European Union’s decision to block its €1.63 billion ($1.90 billion) purchase of ETraveli.
Blackstone (BX) Eyes $2 Billion ZO Skin Health Exit
Blackstone Inc. (NYSE:BX) is exploring a possible sale of ZO Skin Health, the medical-grade skincare company founded by dermatologist Dr. Zein Obagi.
Smithfield Foods (SFD) Warns of Fresh Pork Loss as Industry Spreads Compress
On September 9, Reuters reported that Smithfield Foods, Inc.
The Goldman Sachs (GS) Deepens AI Push as Competition for Tech Talent Intensifies
On September 8, Reuters reported that The Goldman Sachs Group, Inc.
Visa Positions Itself for the Next Wave of Stablecoin Payments
Visa Inc. (NYSE:V) is expanding its data offering to blockchain-based lenders as demand for stablecoin-linked cards accelerates.
Bristol Myers’ Cancer Therapy Win Strengthens its Oncology Pipeline
Bristol-Myers Squibb Company (NYSE:BMY) said its experimental CAR-T cell therapy, arlocabtagene autoleucel (arlo-cel), met the main goal of a mid-stage trial in patients with ...
Qualcomm’s AI Ambitions Get a Boost From Amazon Partnership
QUALCOMM Incorporated (NASDAQ:QCOM) has struck a long-term partnership with Amazon.com, Inc.
Drug Trial Setbacks Raise Questions Over Novartis (NVS)’s Growth Pipeline
Novartis AG (NYSE:NVS) has suffered a major setback after its experimental drug del-desiran failed a late-stage trial for myotonic dystrophy type 1, a rare muscle-wasting disease...
Aurukun Deal Gives Rio Tinto (RIO) More Bauxite Upside, But Risks Remain
Rio Tinto Group (NYSE:RIO) has agreed to acquire the Aurukun Bauxite Project in Western Cape York, Queensland, from a joint venture between Glencore and Mitsubishi Development...
EverBank-WaFd Merger Could Reshape the Regional Banking Landscape
EverBank Financial has agreed to merge with WaFd, Inc. (NASDAQ:WAFD) in a $3.9 billion reverse merger to create a regional bank with about $75 billion in assets.
Lockheed Martin (LMT)’s HIMARS Win in Sweden Strengthens its European Defense Footprint
Sweden has decided to purchase around 10 Lockheed Martin Corporation (NYSE:LMT) HIMARS launchers plus ammunition in a deal worth roughly $729 million, with deliveries expected...
Wegovy’s Latest Trial Gives Novo Nordisk (NVO) Another Potential Growth Catalyst
Novo Nordisk A/S (NYSE:NVO) has delivered encouraging late-stage data for Wegovy in younger children, with its STEP Young trial showing that 40.4% of children aged 6 to under ...
Illumina and Everpure to Join S&P 500 in September Rebalancing: What it Means for Investors
Illumina, Inc. (NASDAQ:ILMN) and Everpure, Inc.